Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Marshall

Showing results (411-420 of 704) with videos related to

Pageof 71
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 3, 2025
Development of Differential Sublaminar Feedforward Inhibitory Circuits in CA1 Hippocampus Requires <i>Satb2</i>Meretta A Hanson, Noor Bibi, Alireza Safa, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Development of differential sublaminar feedforward inhibitory circuits in CA1 hippocampus requires <i>Satb2</i>Meretta A Hanson, Noor Bibi, Alireza Safa, et al.
Clinical Advances in Hematology & Oncology : H&O|June 12, 2026
Clinical applications of PARP inhibitors in breast, ovarian, and prostate cancer: current insights and future directionsLaura M Linville, Jenna V Canzoniero, Catherine H Marshall, et al.
Bone|January 1, 1992
Comparison of low-dose intramuscular and intravenous salcatonin in the treatment of primary hyperparathyroidismM D Stone, D H Marshall, D J Hosking, et al.
Heart (British Cardiac Society)|June 2, 2007
The obstacles to maximising the impact of public access defibrillation: an assessment of the dispatch mechanism for out-of-hospital cardiac arrestK J Cairns, A J Hamilton, A H Marshall, et al.
Molecular Pharmacology|February 23, 2013
Pharmacology and structure of isolated conformations of the adenosine A₂A receptor define ligand efficacyKirstie A Bennett, Benjamin Tehan, Guillaume Lebon, et al.
Somatic Cell Genetics|November 1, 1979
Regulation of expression of type C virion DNA polymerase (reverse transcriptase) in human x mouse and human x rat hybrid cellsJ D Minna, T H Marshall, S H Brown, et al.
Breast Cancer Research and Treatment|February 11, 2026
Defining prognostic subgroups and treatment outcomes in estrogen receptor low-positive de novo metastatic breast cancerMadelyn F Klugman, Maya Aboumrad, Ruizhe Chen, et al.
Clinical Genetics|July 1, 1980
Immunoglobulin concentration and Gm allotypes in a family with thirty-three cases of myotonic dystrophyB Larsen, G Johnson, E van Loghem, et al.
British Journal of Urology|December 1, 1983
Studies on the prevalence and epidemiology of urinary stone disease in men in LeedsW G Robertson, M Peacock, M Baker, et al.
Pageof 71

Showing results (411-420 of 704) with videos related to

Sort By:
Pageof 71
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 3, 2025
Development of Differential Sublaminar Feedforward Inhibitory Circuits in CA1 Hippocampus Requires <i>Satb2</i>Meretta A Hanson, Noor Bibi, Alireza Safa, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Development of differential sublaminar feedforward inhibitory circuits in CA1 hippocampus requires <i>Satb2</i>Meretta A Hanson, Noor Bibi, Alireza Safa, et al.
Clinical Advances in Hematology & Oncology : H&O|June 12, 2026
Clinical applications of PARP inhibitors in breast, ovarian, and prostate cancer: current insights and future directionsLaura M Linville, Jenna V Canzoniero, Catherine H Marshall, et al.
Bone|January 1, 1992
Comparison of low-dose intramuscular and intravenous salcatonin in the treatment of primary hyperparathyroidismM D Stone, D H Marshall, D J Hosking, et al.
Heart (British Cardiac Society)|June 2, 2007
The obstacles to maximising the impact of public access defibrillation: an assessment of the dispatch mechanism for out-of-hospital cardiac arrestK J Cairns, A J Hamilton, A H Marshall, et al.
Molecular Pharmacology|February 23, 2013
Pharmacology and structure of isolated conformations of the adenosine A₂A receptor define ligand efficacyKirstie A Bennett, Benjamin Tehan, Guillaume Lebon, et al.
Somatic Cell Genetics|November 1, 1979
Regulation of expression of type C virion DNA polymerase (reverse transcriptase) in human x mouse and human x rat hybrid cellsJ D Minna, T H Marshall, S H Brown, et al.
Breast Cancer Research and Treatment|February 11, 2026
Defining prognostic subgroups and treatment outcomes in estrogen receptor low-positive de novo metastatic breast cancerMadelyn F Klugman, Maya Aboumrad, Ruizhe Chen, et al.
Clinical Genetics|July 1, 1980
Immunoglobulin concentration and Gm allotypes in a family with thirty-three cases of myotonic dystrophyB Larsen, G Johnson, E van Loghem, et al.
British Journal of Urology|December 1, 1983
Studies on the prevalence and epidemiology of urinary stone disease in men in LeedsW G Robertson, M Peacock, M Baker, et al.
Pageof 71